secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001104659-25-115056
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn shareholders approve increase in authorized shares to 2.25B; all directors reelected
--------------------------------------------------------------------------------

- Authorized common stock increased from 1.75B to 2.25B shares; approved 671,591,768 For vs 69,716,006 Against.
- All five director nominees elected: Tanya Urbach, Stephen Simes, Ryan Dunlap, Lishomwa Ndhlovu, Karen Brunke.
- Advisory vote on executive compensation passed with 389,864,422 For, 108,351,482 Against.
- Shareholders ratified CBIZ CPAs as auditor for FY ending May 31, 2026; vote 721,348,317 For.
- Advisory vote on frequency of say-on-pay set at one year; 451,446,382 votes for one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000110465925115056/0001104659-25-115056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000110465925115056/cydy-20251121x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-115056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer